Interesting that MSB did not make the codes from medicare for possible COVID treatments. This list was released today and a lot of the stocks listed here shot up 30-40%.
Not that it matters, as given DSMB are the only ones who can look at the data I assume someone from medicare looked at some trials and created new codes, and that ultimately it will come down to MSB's science and the management's ability to roll Rem-L out to the public.
https://www.icd10monitor.com/cms-releases-new-icd-10-pcs-codes-for-covid-19
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-524
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.080(8.25%) |
Mkt cap ! $1.198B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.06 | 99.0¢ | $4.930M | 4.779M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23545 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 339479 | 5 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |